EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database

Rino Toyoshima, Shotaro Aso iD, Hiroki Matsui, Kiyohide Fushimi, Natsumi Hama iD, Riichiro Abe iD, Hideo Yasunaga iD, Shinichi Sato, Sayaka Shibata iD

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70082 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Rino Toyoshima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Acetaminophen, Stevens-Johnson Syndrome, Anti-Inflammatory Agents, Non-Steroidal, Analgesics, Non-Narcotic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life‐threatening mucocutaneous disorders, primarily triggered by medications. Despite the frequent need for antipyretic and analgesic therapy, the impact of nonsteroidal anti‐inflammatory drugs (NSAIDs) and acetaminophen on clinical outcomes in patients with SJS/TEN remains unclear. This study aimed to compare the effects of NSAIDs and acetaminophen use on in‐hospital mortality, infection‐related events, and renal outcomes, with particular attention to the presence or absence of chronic kidney disease (CKD). We conducted a retrospective analysis using a nationwide administrative database of over 1200 acute care hospitals in Japan between July 2010 and March 2022. Adult patients diagnosed with SJS or TEN who received either NSAIDs or acetaminophen within the first 5 days of hospitalization were included. Patients who received both drugs or neither were excluded. Among 8301 eligible patients, 2484 met inclusion criteria. Overall mortality did not differ significantly between groups (4.1% vs. 4.6%; risk difference [RD], −0.6%; 95% confidence interval [CI], −2.5% to 1.4%). In patients without CKD, NSAID use was associated with lower mortality (2.6% vs. 4.3%; RD, −1.7%; 95% CI, −3.4% to 0.0%). Conversely, in patients with CKD, acetaminophen use was associated with lower mortality (12.0% vs. 38.2%; RD, 26.2%; 95% CI, 5.0% to 47.4%). In conclusion, NSAID use may be associated with relatively improved survival compared with acetaminophen in patients without CKD, while acetaminophen appears safer in those with CKD, suggesting that renal function may inform the selection of antipyretic or analgesic therapy when such treatment is unavoidable. As both drugs are known causative agents of SJS/TEN, these results should be interpreted with caution. Further studies are warranted to validate these observational findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenStevens-Johnson SyndromeAnti-Inflammatory Agents, Non-SteroidalAnalgesics, Non-NarcoticHumansRetrospective StudiesMaleFemaleMiddle AgedAgedDatabases, FactualJapanHospital MortalityAdultAged, 80 and overRenal Insufficiency, Chronic

Stichwörter der Autor:innen

Stevens–Johnson syndrome (SJS)acetaminophenchronic kidney disease (CKD)nonsteroidal anti‐inflammatory drugs (NSAIDs)toxic epidermal necrolysis (TEN)

Substanzen

AcetaminophenAnti-Inflammatory Agents, Non-SteroidalAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Department of Health Policy and Informatics, Institute of Science Tokyo Graduate School, Tokyo, Japan.
  • Division of Dermatology, Graduate School of Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

ORCID-Profile: Shotaro Aso, Natsumi Hama, Riichiro Abe, Hideo Yasunaga, Sayaka Shibata

Förderung

  • Ministry of Health, Labour and Welfare
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Agency for Medical Research and Development

Zitieren

APA

Toyoshima, R., Aso, S., Matsui, H., Fushimi, K., Hama, N., Abe, R., Yasunaga, H., Sato, S., & Shibata, S. (2026). Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70082

Vancouver

Toyoshima R, Aso S, Matsui H, Fushimi K, Hama N, Abe R, et al. Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70082

BibTeX
@article{Toyoshima2026,
  author = {Toyoshima, Rino and Aso, Shotaro and Matsui, Hiroki and Fushimi, Kiyohide and Hama, Natsumi and Abe, Riichiro and Yasunaga, Hideo and Sato, Shinichi and Shibata, Sayaka},
  title = {Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70082}
}
Kostenlos starten →